Likewise, changes in the levels of total tau and Aβ1-40/1–42 peptides in vitreous humor from AD patients are clinically predictive of their neuro-cognition state evaluated by Mini-Mental State Exam (MMSE) [76]. The gene discussed is MAPT; the disease is Alzheimer disease.